{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:59:04Z","timestamp":1777557544758,"version":"3.51.4"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Postdoctoral Fellowship Program","award":["GZB20230481"],"award-info":[{"award-number":["GZB20230481"]}]},{"name":"Post-Doctor Research Project, West China Hospital, Sichuan University","award":["2024HXBH149"],"award-info":[{"award-number":["2024HXBH149"]}]},{"name":"Post-Doctor Research Project, West China Hospital, Sichuan University","award":["2024HXBH006"],"award-info":[{"award-number":["2024HXBH006"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303773"],"award-info":[{"award-number":["82303773"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303772"],"award-info":[{"award-number":["82303772"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204490"],"award-info":[{"award-number":["82204490"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2023NSFSC1885"],"award-info":[{"award-number":["2023NSFSC1885"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2024NSFSC1908"],"award-info":[{"award-number":["2024NSFSC1908"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Research, Development Program of Sichuan Province","award":["2023YFS0306"],"award-info":[{"award-number":["2023YFS0306"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Composite lymphoma (CL) is rare. We conducted an analysis of 53\u2005329 cases of diffuse large B-cell lymphoma (DLBCL), 17,916 cases of Hodgkin lymphoma (HL), and 869 cases of composite HL and DLBCL from the SEER database diagnosed between 2000 and 2019. Incidence rates showed increasing trends with age for CL and DLBCL, while HL exhibited 2 peak incidence rates: 42.05 (95% CI: 40.88-43.25) per million for the age group 20-24 and 43.20 (95% CI: 41.13-45.35) per million for 75-79. Higher incidence rates were observed in males (CL, 0.68, 95% CI: 0.62-0.74; HL, 29.65, 95% CI: 29.27-30.03; DLBCL, 86.18, 95% CI: 85.51-86.86) compared to females (CL, 0.40, 95% CI: 0.36-0.45; HL, 23.15, 95% CI: 22.83-23.49; DLBCL, 57.56, 95% CI: 57.06-58.06; P\u2005&amp;lt;\u2005.001). We first identified independent prognostic factors for composite HL and DLBCL, which were used for development of a scoring nomogram. Factors such as primary tumor site, marital status, chemotherapy, and sex predominantly influence short-term survival, while Ann Arbor stage plays a significant role in long-term survival. Furthermore, there were notable differences in demographic characteristics, survival outcomes, and death cause among CL, HL, and DLBCL. This study provides the first comprehensive report of composite HL and DLBCL.<\/jats:p>","DOI":"10.1093\/oncolo\/oyae221","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T21:22:23Z","timestamp":1744492943000},"source":"Crossref","is-referenced-by-count":2,"title":["Epidemiology characteristics and clinical outcomes of composite Hodgkin lymphoma and diffuse large B-cell lymphoma using machine learning"],"prefix":"10.1093","volume":"30","author":[{"given":"Ailin","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Hematology, West China Hospital, Sichuan University , 610041, Chengdu, Sichuan ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Hematology, West China Hospital, Sichuan University , 610041, Chengdu, Sichuan ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weishi","family":"Cheng","sequence":"additional","affiliation":[{"name":"Peking Union Medical College, Chinese Academy of Medical Sciences , 100730,\u00a0Beijing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqi","family":"Yang","sequence":"additional","affiliation":[{"name":"West School of Medicine, Sichuan University , 610041, Chengdu, Sichuan ,\u00a0","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Hematology, West China Hospital, Sichuan University , 610041, Chengdu, Sichuan ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Niu","sequence":"additional","affiliation":[{"name":"Department of Hematology, West China Hospital, Sichuan University , 610041, Chengdu, Sichuan ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,4,12]]},"reference":[{"issue":"5","key":"2025043006463961200_CIT0001","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/s0046-8177(00)80046-5","article-title":"Composite lymphoma","volume":"31","author":"Fend","year":"2000","journal-title":"Hum Pathol"},{"issue":"12","key":"2025043006463961200_CIT0002","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.prp.2016.11.002","article-title":"Composite lymphoma with diffuse large B-cell lymphoma and classical Hodgkin lymphoma components: a case report and review of the literature","volume":"212","author":"Goyal","year":"2016","journal-title":"Pathol Res Pract"},{"issue":"10","key":"2025043006463961200_CIT0003","doi-asserted-by":"publisher","first-page":"e435","DOI":"10.1016\/S1470-2045(14)70153-6","article-title":"Pathogenesis, diagnosis, and treatment of composite lymphomas","volume":"15","author":"K\u00fcppers","year":"2014","journal-title":"Lancet Oncol"},{"issue":"4","key":"2025043006463961200_CIT0004","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/1097-0142(195607\/08)9:4&lt;792::aid-cncr2820090429&gt;3.0.co;2-b","article-title":"Follicular lymphoma; a re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases","volume":"9","author":"Hicks","year":"1956","journal-title":"Cancer"},{"issue":"4","key":"2025043006463961200_CIT0005","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/ajcp\/99.4.445","article-title":"Composite lymphoma and related disorders","volume":"99","author":"Kim","year":"1993","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"2025043006463961200_CIT0006","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1309\/DDGL-WRV3-KR91-64G7","article-title":"Composite recurrent hodgkin lymphoma and diffuse large B-cell lymphoma: one clone, two faces","volume":"126","author":"Huang","year":"2006","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"2025043006463961200_CIT0007","doi-asserted-by":"publisher","first-page":"106669","DOI":"10.1016\/j.leukres.2021.106669","article-title":"Survival among patients with composite and sequential lymphoma between primary mediastinal lymphoma\/diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a population-based study","volume":"111","author":"Tao","year":"2021","journal-title":"Leuk Res"},{"issue":"1","key":"2025043006463961200_CIT0008","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1186\/s12885-021-08683-x","article-title":"Causes of death and effect of non-cancer-specific death on rates of overall survival in adult classic Hodgkin lymphoma: a populated-based competing risk analysis","volume":"21","author":"Gao","year":"2021","journal-title":"BMC Cancer"},{"issue":"4","key":"2025043006463961200_CIT0009","doi-asserted-by":"publisher","first-page":"846","DOI":"10.3349\/ymj.2016.57.4.846","article-title":"The roles of radiotherapy and chemotherapy in the era of multimodal treatment for early-stage nasal-type extranodal natural killer\/T-cell lymphoma","volume":"57","author":"Kim","year":"2016","journal-title":"Yonsei Med J"},{"issue":"3","key":"2025043006463961200_CIT0010","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3390\/cancers15030983","article-title":"Long-term survival of patients with mantle cell lymphoma after total body irradiation, high-dose chemotherapy and stem cell transplantation: a monocenter study","volume":"15","author":"Kr\u00f6ger","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2025043006463961200_CIT0011","doi-asserted-by":"publisher","first-page":"e45455","DOI":"10.2196\/45455","article-title":"Epidemiology and a predictive model of prognosis index based on machine learning in primary breast lymphoma: population-Based Study","volume":"9","author":"Yu","year":"2023","journal-title":"JMIR Public Health Surveill"},{"issue":"1","key":"2025043006463961200_CIT0012","doi-asserted-by":"publisher","first-page":"919012","DOI":"10.3389\/fimmu.2022.919012","article-title":"Machine learning models for the diagnosis and prognosis prediction of high-grade B-cell lymphoma","volume":"13","author":"Kong","year":"2022","journal-title":"Front Immunol"},{"issue":"26","key":"2025043006463961200_CIT0013","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1182\/bloodadvances.2017009472","article-title":"Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL","volume":"1","author":"Pilichowska","year":"2017","journal-title":"Blood Adv"},{"issue":"9","key":"2025043006463961200_CIT0014","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ajh.24082","article-title":"Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort","volume":"90","author":"Evens","year":"2015","journal-title":"Am J Hematol"},{"issue":"8","key":"2025043006463961200_CIT0015","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.3324\/haematol.2021.280543","article-title":"Distinct genetic alterations in Burkitt-like lymphoma with 11q aberration and Burkitt lymphoma: a novel case report of composite lymphoma","volume":"107","author":"Kim","year":"2022","journal-title":"Haematologica"},{"issue":"2","key":"2025043006463961200_CIT0016","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3322\/caac.21438","article-title":"Hodgkin lymphoma: a review and update on recent progress","volume":"68","author":"Shanbhag","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"2025043006463961200_CIT0017","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1182\/bloodadvances.2021005794","article-title":"Polatuzumab vedotin plus bendamustine and rituximab in relapsed\/refractory DLBCL: survival update and new extension cohort data","volume":"6","author":"Sehn","year":"2022","journal-title":"Blood Adv"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/30\/4\/oyae221\/62921371\/oyae221.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/30\/4\/oyae221\/62921371\/oyae221.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T10:46:50Z","timestamp":1746010010000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/doi\/10.1093\/oncolo\/oyae221\/8112689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4,4]]}},"URL":"https:\/\/doi.org\/10.1093\/oncolo\/oyae221","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2025,4]]},"article-number":"oyae221"}}